Tag: Biogen

Lecanemab Phase 3 Trial Meetings Primary Endpoint

Science

Lecanemab Phase 3 Trial Meetings Primary Endpoint

28/09/2022 Dementia Researcher

Drilling Down into the CMS Aduhelm Decision

Research News

Drilling Down into the CMS Aduhelm Decision

26/04/2022 Alz Forum

Donanemab Puts Plasma p-Tau, Remote Assessments to the Test

Science

Donanemab Puts Plasma p-Tau, Remote Assessments to the Test

23/11/2021 Dementia Researcher

Blog – The Aduhelm Paradox

Guest blog, Science

Blog – The Aduhelm Paradox

04/07/2021 Dr Sam Moxon

Biogen Aducanumab drug approved by FDA

Research News

Biogen Aducanumab drug approved by FDA

07/06/2021 Dementia Researcher

Biogen Asks FDA To Approve Aducanumab

Dissemination

Biogen Asks FDA To Approve Aducanumab

09/07/2020 Alz Forum

Translate »